Return On Equity	(Mar 31 2026) 2026	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2022) 2022
Y / Y Equity Change	84.78 %	-7.06 %	98.83 %	14.82 %	56.15 %
Y / Y Net Income Change	-	-	464.56 %	-59.97 %	74.87 %
Return On Equity	45.38 %	-	34.92 %	12.3 %	35.28 %

ELTP all Ratios >> Back to ELTP Management Effectiveness >> See Quarterly ELTP Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Mar 31 2026) ROE improved to 45.38 % compare to previous year, due to net income growth.

Financial Statements
Elite Pharmaceuticals Inc 's Equity	$ 99 Millions	Annual ELTP's Balance sheet
Elite Pharmaceuticals Inc 's Annual Income	$ 45 Millions	Annual ELTP's Income Statement
Where are ELTP's Income coming from?		Visit ELTP's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.